InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: pumper_stumper post# 159904

Monday, 09/19/2022 10:29:58 PM

Monday, September 19, 2022 10:29:58 PM

Post# of 198711
So the statement phrased as a question had no basis in reality, then? lol

Of course a question can be backed up with links? That's what makes a question informed, yes? Anyway, here are a couple of links that do provide a basis in something cite-able?

On October 7, 2021, the Company entered into a MDSA and PSA with Samsung Biologics Co., Ltd to advance the development of the Company’s human clone antibody program and clinical testing.

Quarterly Report for period 06.30.2022, page 12



After confirming antibody activity, the Company's CDMO partner Samsung Biologics produces recombinant antibodies in their proprietary, FDA-approved stable CHO cell line suitable for Clinical Application.

Quarterly Report for period 06.30.2022, page 17



So as we can see, Samsung is still working with ENZC according to the 2022 Q2 filings, and they really do have an ongoing partnership?




.

Sometimes I edit my posts in the first 15 minutes. Refresh for the latest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News